UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark one)
| |X| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| |_| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM: NOT APPLICABLE
| Delaware | 74-2717523 | ||
| (State or other jurisdiction of | (I.R.S. Employer | ||
| incorporation or organization) | Identification Number) | ||
| 888 Seventh Avenue | (212) 887-6800 | ||
| New York, NY 10106 | (Registrants telephone number, including area code) | ||
| (Address of principal executive offices) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes |X| No |_|
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes |X| No |_|
As of July 23, 2004, the registrant had 93,173,452 shares of common stock outstanding, consisting of 51,874,804 shares of Series A Common Stock, and 41,298,648 shares of Series B Common Stock.
| Part I |
Financial Information |
Page No.
|
|
|
Item 1. |
Financial Statements |
||
|
Condensed Consolidated Balance Sheets as of June 30, 2004 (unaudited) and December 31, 2003 |
1 |
||
|
Condensed Consolidated Statements of Income for the Three and Six Months Ended |
|||
|
June 30, 2004 and 2003 (unaudited) |
3 |
||
|
Condensed Consolidated Statements of Cash Flows for the Six Months Ended |
|||
|
June 30, 2004 and 2003 (unaudited) |
4 |
||
|
Notes to Condensed Consolidated Financial Statements |
5 |
||
|
Item 2. |
Managements Discussion and Analysis of Financial
Condition |
15 |
|
|
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
21 |
|
|
Item 4. |
Controls and Procedures |
21 |
|
| Part II |
Other Information |
||
|
Item 2. |
Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities |
22 |
|
|
Item 4. |
Submission of Matters to a Vote of Security Holders |
23 |
|
|
Item 6. |
Exhibits and Reports on Form 8-K |
24 |
|
|
Signatures |
25 |
||
|
Exhibit Index |
26 |
||
|
Certifications |
|||
| June
30, 2004 (Unaudited) |
December
31, 2003
|
|||
|
(In thousands) |
||||
|
Assets |
||||
|
Current assets: |
||||
|
Cash and cash equivalents |
$ 138,067 |
$ 71,528 |
||
|
Accounts receivable, net |
151,460 |
147,455 |
||
|
Program and barter rights |
17,383 |
54,725 |
||
|
Deferred income taxes |
5,178 |
5,178 |
||
|
Other |
6,770 |
5,786 |
||
|
|
|
|||
|
Total current assets |
318,858 |
284,672 |
||
|
|
|
|||
|
Property, plant and equipment, net |
283,015 |
288,290 |
||
|
|
|
|||
|
Intangible assets, net |
2,409,080 |
2,412,071 |
||
|
|
|
|||
|
Goodwill |
732,217 |
732,217 |
||
|
|
|
|||
|
Other noncurrent assets: |
||||
|
Deferred financing and acquisition costs, net |
13,848 |
14,592 |
||
|
Investments |
33,341 |
34,059 |
||
|
Program and barter rights |
892 |
2,562 |
||
|
Other |
28,077 |
30,624 |
||
|
|
|
|||
|
Total other noncurrent assets |
76,158 |
81,837 |
||
|
|
|
|||
|
Total assets |
$3,819,328 |
$3,799,087 |
||
|
|
|
|||
(Continued)
| 1 |
|
|
June 30, 2004
(Unaudited) |
December
31, 2003
|
||
| (In thousands) | ||||
|
Liabilities and Stockholders Equity |
||||
|
Current liabilities: |
||||
|
Accounts payable |
$ 9,103 |
$ 9,834 |
||
|
Accrued liabilities |
57,491 |
50,833 |
||
|
Program and barter rights payable |
18,563 |
55,741 |
||
|
Payable to The Hearst Corporation |
3,684 |
5,925 |
||
|
Other |
5,719 |
8,085 |
||
|
|
|
|||
|
Total current liabilities |
94,560 |
130,418 |
||
|
|
|
|||
|
Noncurrent liabilities: |
||||
|
Program and barter rights payable |
2,022 |
4,141 |
||
|
Long-term debt |
882,321 |
882,409 |
||
|
Note payable to Capital Trust |
206,186 |
206,186 |
||
|
Deferred income taxes |
891,067 |
882,098 |
||
|
Other liabilities |
22,534 |
21,453 |
||
|
|
|
|||
|
Total noncurrent liabilities |
2,004,130 |
1,996,287 |
||
|
|
|
|||
|
Series A and B preferred stock to be redeemed |
16,719 |
18,319 |
||
|
|
|
|||
|
Stockholders equity: |
||||
| Preferred stock | | | ||
|
Series A common stock |
551 |
547 |
||
|
Series B common stock |
413 |
413 |
||
|
Additional paid-in capital |
1,277,180 |
1,269,514 |
||
|
Retained earnings |
511,723 |
469,537 |
||
|
Accumulated other comprehensive loss, net |
(5,249 |
) |
(5,249 |
) |
|
Treasury stock, at cost |
(80,699 |
) |
(80,699 |
) |
|
|
|
|||
|
Total stockholders equity |
1,703,919 |
1,654,063 |
||
|
|
|
|||
|
Total liabilities and stockholders equity |
$3,819,328 |
$3,799,087 |
|
|
|
|
|
|||
See notes to condensed consolidated financial statements.
| 2 |
| Three
Months Ended June 30, |
Six
Months Ended June 30, |
|||||||
| 2004
|
2003
|
2004
|
2003
|
|||||
| (Unaudited)
(In thousands, except per share data) |
||||||||
|
Total revenue |
$197,958 |
$179,605 |
$364,822 |
$328,881 |
||||
|
Station operating expenses: |
||||||||
|
Salaries, benefits and other operating costs |
87,210 |
81,028 |
171,804 |
160,861 |
||||
|
Amortization of program rights |
14,818 |
15,830 |
30,129 |
31,922 |
||||
|
Depreciation and amortization |
12,356 |
13,136 |
24,851 |
24,096 |
||||
|
Corporate general and administrative expenses |
6,113 |
4,884 |
11,702 |
9,758 |
||||
|
|
|
|
|
|||||
|
Operating income |
77,461 |
64,727 |
126,336 |
102,244 |
||||
|
Interest expense, net |
16,005 |
17,351 |
32,421 |
34,760 |
||||
|
Interest expense, net Capital Trust |
3,750 |
3,750 |
7,500 |
7,500 |
||||
|
Equity in income of affiliates, net |
463 |
370 |
662 |
234 |
||||
|
|
|
|
|
|||||
|
Income before income taxes |
58,169 |
43,996 |
87,077 |
60,218 |
||||
|
Income taxes |
22,162 |
16,718 |
33,176 |
22,883 |
||||
|
|
|
|
|
|||||
|
Net income |
36,007 |
27,278 |
53,901 |
37,335 |
||||
|
Less preferred stock dividends |
272 |
297 |
544 |
615 |
||||
|
|
|
|
|
|||||
|
Income applicable to common stockholders |
$ 35,735 |
$ 26,981 |
$ 53,357 |
$ 36,720 |
||||
|
|
|
|
|
|||||
|
Income per common share basic: |
$ 0.38 |
$ 0.29 |
$ 0.57 |
$ 0.40 |
||||
|
|
|
|
|
|||||
|
Number of common shares used in the calculation |
93,087 |
92,554 |
92,995 |
92,495 |
||||
|
|
|
|
|
|||||
|
Income per common share diluted: |
$ 0.37 |
$ 0.29 |
$ 0.57 |
$ 0.40 |
||||
|
|
|
|
|
|||||
|
Number of common shares used in the calculation |
101,601 |
92,963 |
93,641 |
92,856 |
||||
|
|
|
|
|
|||||
|
Dividends per common share declared |
$ 0.06 |
$ |
$ 0.12 |
$ |
||||
|
|
|
|
|
|||||
See notes to condensed consolidated financial statements.
| 3 |
| Six
Months Ended June 30,
|
||||
| 2004
|
2003
|
|||
| (Unaudited)
(In thousands) |
||||
|
Operating Activities |
||||
|
Net income |
$ 53,901 |
$37,335 |
||
|
Adjustments to reconcile net income
|
||||
|
Depreciation |
21,860 |
22,863 |
||
|
Amortization of intangible assets |
2,991 |
1,233 |
||
|
Amortization of program rights |
30,129 |
31,922 |
||
|
Program payments |
(30,386 |
) |
(31,161 |
) |
|
Amortization of deferred financing costs |
1,163 |
1,455 |
||
|
Deferred income taxes |
8,969 |
8,611 |
||
|
Equity in income of affiliates, net |
(662 |
) |
(234 |
) |
|
Provision for doubtful accounts |
(408 |
) |
144 |
|
|
Loss on disposal of fixed assets |
7 |
34 |
||
|
Dividends received from affiliates |
1,330 |
|
||
|
Changes in operating assets and liabilities: |
||||
|
Accounts receivable |
(3,707 |
) |
616 |
|
|
Other assets |
1,563 |
1,640 |
||
|
Accounts payable and accrued liabilities |
5,888 |
(9,690 |
) |
|
|
Other liabilities |
(3,579 |
) |
(1,566 |
) |
|
|
|
|||
|
Net cash provided by operating activities |
89,059 |
63,202 |
||
|
|
|
|||
|
Investing Activities |
||||
|
Purchases of property, plant, and equipment: |
||||
|
Maintenance |
(9,018 |
) |
(6,764 |
) |
|
Special projects/towers |
(7,357 |
) |
(4,828 |
) |
|
Digital |
(592 |
) |
(3,011 |
) |
|
Other, net |
45 |
142 |
||
|
|
|
|||
|
Net cash used in investing activities |
(16,922 |
) |
(14,461 |
) |
|
|
|
|||
|
Financing Activities |
||||
|
Dividends paid on common stock |
(11,147 |
) |
|
|
|
Dividends paid on preferred stock |
(544 |
) |
(615 |
) |
|
Redemption of preferred stock |
(1,600 |
) |
|
|
|
Proceeds from employee stock purchase plan |
1,100 |
1,069 |
||
|
Proceeds from stock option exercises |
6,681 |
1,496 |
||
|
Borrowings from Credit Facility |
|
172,150 |
||
|
Repayments to Credit Facility |
|
(220,150 |
) |
|
|
Principal payments on capital lease obligations |
(88 |
) |
(62 |
) |
|
|
|
|||
|
Net cash used in financing activities |
(5,598 |
) |
(46,112 |
) |
|
|
|
|||
|
Increase in cash and cash equivalents |
66,539 |
2,629 |
||
|
Cash and cash equivalents at beginning of period |
71,528 |
4,442 |
||
|
|
|
|||
|
Cash and cash equivalents at end of period |
$138,067 |
$ 7,071 |
||
|
|
|
|||
|
Supplemental Cash Flow Information: |
||||
|
Cash paid during the period: |
||||
|
Interest |
$ 31,895 |
$33,342 |
||
|
|
|
|||
|
Interest on Note payable to Capital Trust |
$ 7,500 |
$ 7,500 |
||
|
|
|
|||
|
Income taxes, net of refunds of $1,218 and $6 in the six months |
||||
|
ended June 30, 2004 and 2003, respectively |
$ 18,481 |
$11,971 |
||
|
|
|
|||
|
Non-cash investing and financing activities- |
||||
|
Capital lease obligations entered into during the period |
$ |
$ 229 |
||
|
|
|
|||
See notes to condensed consolidated financial statements.
| 4 |
The condensed consolidated financial statements include the accounts of Hearst-Argyle Television, Inc. and its wholly-owned subsidiaries (the Company), except for the Companys wholly-owned subsidiary trust which was required to be de-consolidated upon adoption of the Financial Accounting Standards Board (FASB) Interpretation No. 46 (revised December 2003), Consolidation of Variable Interest Entities (FIN 46(R)). The Company adopted FIN 46(R) as of December 31, 2003. See New Accounting Pronouncements below. With the exception of the unconsolidated subsidiary trust, all significant inter-company accounts have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements and should be read in conjunction with the Companys consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2003, filed with the Securities and Exchange Commission, as amended. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are normal and recurring in nature. Operating results for the three and six-month periods ended June 30, 2004 and 2003 are not necessarily indicative of the results that may be expected for a full year.
In December 2003, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 132 (revised 2003), Employers Disclosures about Pensions and Other Postretirement Benefits an amendment of FASB Statements No. 87, 88 and 106 (SFAS 132(R)). SFAS 132(R) is effective for fiscal years ending after December 15, 2003. Interim disclosure requirements under SFAS 132(R) are effective for interim periods beginning after December 15, 2003, and required disclosures related to estimated benefit payments will be effective for fiscal years ending after June 15, 2004. SFAS 132(R) replaces the disclosure requirements in SFAS No. 87, Employers Accounting for Pensions (SFAS 87), SFAS No. 88, Employers Accounting for Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits, and SFAS 106, Employers Accounting for Postretirement Benefits Other Than Pensions (SFAS 106). SFAS 132(R) addresses disclosures only and does not address measurement and recognition accounting for pension and postretirement benefits. SFAS 132(R) requires additional disclosures related to the description of plan assets including investment strategies, plan obligations, cash flows and net periodic benefit cost of defined benefit pension and other defined benefit postretirement plans. Effective December 31, 2003, the Company adopted the disclosure requirements of SFAS 132(R) with the exception of future expected benefit payments, which becomes effective for the Company for year ending December 31, 2004.
In December 2003, the FASB issued FIN 46(R), which served to clarify the guidance in Financial Interpretation No. 46, Consolidation of Variable Interest Entities (FIN 46), and provided additional guidance surrounding the application of FIN 46. FIN 46 establishes consolidation criteria for entities for which control is not easily discernable under Accounting Research Bulletin 51, Consolidated Financial Statements, which is based on the premise that holders of an entity control the entity by virtue of voting rights. FIN 46(R) provides guidance for identifying the party with a controlling financial interest resulting from arrangements or financial interests rather than from voting interests. FIN 46 established standards for determining the circumstances under which an entity (defined as a variable interest entity) should be consolidated based upon an evaluation of financial interests and other arrangements rather than voting control. FIN 46 also requires disclosure about any variable interest entities that the Company is not required to consolidate, but in which it has a significant variable interest. Application of FIN 46(R) is required for companies that have interests in those entities that are considered to be special-purpose entities, beginning in periods ending after December 15, 2003, and application is required for interests in all other types of entities beginning in periods ending after March 15, 2004.
The Company adopted and applied the provisions of FIN 46(R) as of December 31, 2003 with respect to its wholly-owned trust subsidiary, the Hearst-Argyle Capital Trust (hereafter the Capital Trust), which is considered to be a special-purpose entity. The adoption of FIN 46(R) required the Company to de-consolidate the Capital Trust in its financial statements. In order to present the Capital Trust as an unconsolidated subsidiary, the Company adjusted the presentation in its condensed consolidated balance
| 5 |
sheets as follows, for all periods presented: (i) reclassified the amount of $200.0 million, which was previously classified as Company obligated redeemable convertible preferred securities of subsidiary trust holding solely parent company debentures to Note payable to Capital Trust; (ii) presented an investment in the Capital Trust of $6.2 million, which is included under Investments on the condensed consolidated balance sheets; and (iii) presented a long-term note payable to the Capital Trust of $6.2 million, which is included under Note payable to Capital Trust,bringing the total Note payable to Capital Trust to $206.2 million on the condensed consolidated balance sheets. Once the redeemable convertible preferred securities have been redeemed or reach maturity, the investment in the Capital Trust of $6.2 million will be offset by the long-term note payable to the Capital Trust of $6.2 million, resulting in no effect to the Companys consolidated income statement. In addition, the Company adjusted the presentation in its consolidated income statements in all periods presented to reclassify the amounts previously recorded as Dividends on redeemable convertible preferred securities to Interest expense, net Capital Trust. These changes required under FIN 46(R) represent financial statement presentation only and are not a result of any changes to the legal, financial, or operating structure of the Capital Trust. Other than the de-consolidation of the Capital Trust, the adoption of FIN 46(R) did not impact the Companys financial statements.
In December 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) was signed into law. The Act provides a federal subsidy to sponsors of retiree healthcare benefit plans that provide a prescription drug benefit that is at least actuarially equivalent to Medicare Part D. In May 2004, the FASB staff issued FASB Staff Position No. 106-2, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 which supercedes FASB Staff Position No. 106-1, Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003, and is effective for interim or annual periods beginning after June 15, 2004. We are currently evaluating the effects of the Act on our post-retirement benefit plans and its participants; therefore, the Companys accumulated post-retirement benefit obligation and net post-retirement benefit cost do not reflect the effects of the Act.
In March 2004, the Emerging Issues Task Force (EITF) reached a consensus on EITF Issue No. 03-16, Accounting for Investments in Limited Liability Companies (EITF No. 03-16), which requires investments in limited liability companies that have separate ownership accounts for each investor to be accounted for similar to a limited partnership investment under Statement of Position No. 78-9, Accounting for Investments in Real Estate Ventures. Investors are required to apply the equity method of accounting to their investments with any ownership interest greater than 3-5%. EITF No. 03-16 is effective for reporting periods beginning after June 15, 2004. The Company does not believe that adoption of EITF No. 03-16 will have a material effect on the Companys financial statements.
| 6 |
The Company accounts for employee stock-based compensation under Accounting Principles Board (APB) Opinion No. 25, Stock Issued to Employees (APB 25) and related interpretations. Under APB 25, because the exercise price of the Companys employee stock options equals the market price of the underlying stock on the date of grant, the stock options have no intrinsic value and therefore no compensation expense is recognized. The Company has adopted the disclosure-only provisions of SFAS No. 123, Accounting For Stock-Based Compensation (SFAS 123). Under SFAS 123, options are valued at their date of grant and then expensed over their vesting period.
The following table details the effect on net income and earnings per share had compensation expense been recorded based on the fair value method under SFAS 123, as amended, utilizing the Black-Scholes option valuation model:
|
|
Three
Months Ended June 30,
|
Six
Months Ended June 30,
|
||||||
| (Unaudited) | (Unaudited) | |||||||
| (In thousands, except per share da | ||||||||